Enliven Therapeutics, Inc. (ELVN) analyst actions
Rating and price-target actions on ELVN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ELVN overview →
1 measured ELVN analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year | Press release | -0.28% | -0.38% |
Keep exploring
More ELVN: earnings → · SEC filings → · ELVN overview →